Levogastrol OD 75 Tablet SR contains Levosulpiride 75 mg as its active ingredient, a selective dopamine D2 receptor antagonist primarily used for the treatment of gastrointestinal motility disorders. This sustained-release formulation ensures prolonged therapeutic action, enhancing patient compliance by allowing once-daily dosing. Levosulpiride exerts prokinetic and antiemetic effects by modulating dopaminergic pathways in the gastrointestinal tract and central nervous system, thereby improving gastric emptying and reducing symptoms such as nausea, vomiting, bloating, and abdominal discomfort associated with functional dyspepsia, gastroparesis, and gastroesophageal reflux disease (GERD). Additionally, Levosulpiride has demonstrated efficacy in managing psychiatric conditions such as depression and schizophrenia due to its selective dopamine antagonism. Levogastrol OD 75 Tablet SR is indicated for adults requiring long-term management of functional gastrointestinal disorders and related symptoms. It should be used under medical supervision, with caution advised in patients with a history of extrapyramidal symptoms, prolactin-dependent tumors, or renal impairment. Common adverse effects may include drowsiness, dizziness, and mild gastrointestinal disturbances. Contraindications include hypersensitivity to Levosulpiride and concurrent use with other dopamine antagonists. Regular monitoring is recommended to assess therapeutic response and detect potential side effects.